Work

Treatment outcomes with purine nucleoside analog alone or with rituximab for hairy cell leukemia at first relapse

Year: 2022

Type: article

Study design: Observational Study

Source: European Journal Of Haematology

DOI: 10.1111/ejh.13744

Authors: Rachel Hu, Wei Wei, Agrima Mian, Kristen Gonter‐Aubin, Charlene Kabel, Anthony Mato, Deborah M. Stephens, Ashley Hanlon, Sirin Khajavian, Mazyar Shadman, Danielle Brander, Yazan Madanat, Jae H. Park, Martin Tallman, Javier Pinilla‐Ibarz, Brian T. Hill

Institutions: Cleveland Clinic, Moffitt Cancer Center, Memorial Sloan Kettering Cancer Center, Huntsman Cancer Institute, Duke Medical Center, Seattle Cancer Care Alliance, University of Washington

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4205423998

FWCI: 0.155

Cites: 10

Cited by: 1

Related to: 10